We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
6151
Arbutus Biopharma
ABUS
$879M
$1K ﹤0.01%
360
-723
-67% -$1.17K
ACIU icon
6152
AC Immune
ACIU
$237M
$1K ﹤0.01%
134
-350
-72% -$2.33K
ADAP
6153
DELISTED
Adaptimmune Therapeutics
ADAP
$1K ﹤0.01%
526
-1,117
-68% -$1.19K
AKBA icon
6154
PUT
Akebia Therapeutics
AKBA
$359M
$1K ﹤0.01%
200
AQST icon
6155
Aquestive Therapeutics
AQST
$471M
$1K ﹤0.01%
159
-652
-80% -$3.39K
ARAY icon
6156
PUT
Accuray
ARAY
$34.2M
$1K ﹤0.01%
300
BBDC icon
6157
Barings BDC
BBDC
$868M
$1K ﹤0.01%
89
-41
-32% -$421
BCSF icon
6158
Bain Capital Specialty
BCSF
$821M
$1K ﹤0.01%
+31
New +$583
SLAI
6159
DELISTED
SOLAI Ltd ADS
SLAI
$1K ﹤0.01%
2
-3
-60% -$2.05K
CGEN icon
6160
Compugen
CGEN
$219M
$1K ﹤0.01%
+154
New +$792
CLLS
6161
Cellectis
CLLS
$287M
$1K ﹤0.01%
71
-290
-80% -$3.87K
CRF
6162
Cornerstone Total Return Fund
CRF
$1.15B
$1K ﹤0.01%
77
EVGN icon
6163
Evogene
EVGN
$5.94M
$1K ﹤0.01%
70
GILT icon
6164
Gilat Satellite Networks
GILT
$849M
$1K ﹤0.01%
172
GSAT icon
6165
Globalstar
GSAT
$10.5B
$1K ﹤0.01%
+155
New +$937
IEZ icon
6166
iShares US Oil Equipment & Services ETF
IEZ
$360M
$1K ﹤0.01%
51
JFIN
6167
Jiayin Group
JFIN
$116M
$1K ﹤0.01%
+136
New +$1.11K
NLY icon
6168
CALL
Annaly Capital Management
NLY
$17.3B
$1K ﹤0.01%
25
-5,275
-100% -$192K
NWG icon
6169
PUT
NatWest
NWG
$76.4B
$1K ﹤0.01%
186
+93
+100% +$582
PFSI icon
6170
PennyMac Financial
PFSI
$3.91B
$1K ﹤0.01%
27
-57,477
-100% -$1.87M
PGEN icon
6171
PUT
Precigen
PGEN
$2.16B
$1K ﹤0.01%
100
-1,400
-93% -$7.88K
TAC icon
6172
TransAlta
TAC
$4.04B
$1K ﹤0.01%
100
VST icon
6173
PUT
Vistra
VST
$51.6B
$1K ﹤0.01%
65
VSTM icon
6174
Verastem
VSTM
$530M
$1K ﹤0.01%
37
-532
-93% -$7.65K
KA
6175
DELISTED
Kineta, Inc. Common Stock
KA
$1K ﹤0.01%
2
-48
-96% -$10.8K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.